NO20092726L - Frysetorket, injiserbar, framasoytisk kombinasjon av halvsyntetiske vincaalkoider og karbohydrater som er stabile ved romtemperatur - Google Patents

Frysetorket, injiserbar, framasoytisk kombinasjon av halvsyntetiske vincaalkoider og karbohydrater som er stabile ved romtemperatur

Info

Publication number
NO20092726L
NO20092726L NO20092726A NO20092726A NO20092726L NO 20092726 L NO20092726 L NO 20092726L NO 20092726 A NO20092726 A NO 20092726A NO 20092726 A NO20092726 A NO 20092726A NO 20092726 L NO20092726 L NO 20092726L
Authority
NO
Norway
Prior art keywords
freeze
semi
stable
room temperature
dried
Prior art date
Application number
NO20092726A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Dominique Ibarra
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092726(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20092726L publication Critical patent/NO20092726L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår farmasøytiske sammensetninger som består av et semisyntetisk derivat av vinkaalkaloid, stabilt ved romtemperatur, hvori nevnte derivat er tilstede i form av et frysetørket produkt oppnådd i nærvær av minst ett karbohydrat.
NO20092726A 2006-12-29 2009-07-20 Frysetorket, injiserbar, framasoytisk kombinasjon av halvsyntetiske vincaalkoider og karbohydrater som er stabile ved romtemperatur NO20092726L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
US89705907P 2007-01-24 2007-01-24
PCT/EP2007/064612 WO2008080968A1 (en) 2006-12-29 2007-12-28 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Publications (1)

Publication Number Publication Date
NO20092726L true NO20092726L (no) 2009-07-20

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092726A NO20092726L (no) 2006-12-29 2009-07-20 Frysetorket, injiserbar, framasoytisk kombinasjon av halvsyntetiske vincaalkoider og karbohydrater som er stabile ved romtemperatur

Country Status (24)

Country Link
US (1) US8304424B2 (no)
EP (1) EP2120934B1 (no)
JP (1) JP2010514737A (no)
KR (1) KR20090097883A (no)
CN (1) CN101534821B (no)
AR (1) AR064715A1 (no)
AU (1) AU2007341231B2 (no)
BR (1) BRPI0722076A2 (no)
CA (1) CA2673232A1 (no)
CL (1) CL2007003838A1 (no)
FR (1) FR2910812B1 (no)
HK (1) HK1130439A1 (no)
IL (1) IL199556A (no)
MA (1) MA30892B1 (no)
MX (1) MX2009006949A (no)
NO (1) NO20092726L (no)
NZ (1) NZ576583A (no)
RU (1) RU2449791C2 (no)
SA (1) SA07280720B1 (no)
TN (1) TN2009000258A1 (no)
TW (1) TWI415631B (no)
UA (1) UA96977C2 (no)
WO (1) WO2008080968A1 (no)
ZA (1) ZA200903115B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
SG11202101676TA (en) * 2018-08-31 2021-03-30 Fujifilm Irvine Scientific Inc Venting system for a mixing apparatus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HUT54308A (en) * 1989-04-04 1991-02-28 Lilly Co Eli Process for producing immunoglobulin conjugates and medicaments comprising same
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
CA2476494C (en) * 2002-02-22 2010-04-27 Schering Corporation Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
FR2863891B1 (fr) 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
JP4971142B2 (ja) * 2004-05-03 2012-07-11 ヘルメス バイオサイエンシズ インコーポレーティッド 薬物送達に有用なリポソーム
KR101354093B1 (ko) * 2005-03-14 2014-01-24 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
CA2673232A1 (en) 2008-07-10
JP2010514737A (ja) 2010-05-06
RU2449791C2 (ru) 2012-05-10
TW200833369A (en) 2008-08-16
ZA200903115B (en) 2010-04-28
CL2007003838A1 (es) 2008-07-04
EP2120934B1 (en) 2014-05-07
US20100087473A1 (en) 2010-04-08
WO2008080968A1 (en) 2008-07-10
CN101534821A (zh) 2009-09-16
EP2120934A1 (en) 2009-11-25
MA30892B1 (fr) 2009-11-02
KR20090097883A (ko) 2009-09-16
UA96977C2 (ru) 2011-12-26
AU2007341231B2 (en) 2013-03-21
SA07280720B1 (ar) 2012-02-07
US8304424B2 (en) 2012-11-06
TN2009000258A1 (en) 2010-10-18
BRPI0722076A2 (pt) 2014-04-08
FR2910812A1 (fr) 2008-07-04
IL199556A (en) 2014-09-30
TWI415631B (zh) 2013-11-21
FR2910812B1 (fr) 2009-03-20
RU2009128327A (ru) 2011-02-10
CN101534821B (zh) 2012-01-25
HK1130439A1 (en) 2009-12-31
MX2009006949A (es) 2009-07-14
AR064715A1 (es) 2009-04-22
AU2007341231A1 (en) 2008-07-10
NZ576583A (en) 2012-01-12

Similar Documents

Publication Publication Date Title
NO20092726L (no) Frysetorket, injiserbar, framasoytisk kombinasjon av halvsyntetiske vincaalkoider og karbohydrater som er stabile ved romtemperatur
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
MX2010006224A (es) Composicion de engomado para lana mineral que comprende un monosacarido y/o un polisacarido y un acido policarboxilico organico, y productos aislantes obtenidos.
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
MY159431A (en) Fibrous materials and compositions
CY1116550T1 (el) Συγκρυσταλλοι (2s, 3r, 4r, 5s, 6r )- 2- (3-((5- (4-φθοροφαινυλο)θειοφαιν-2-υλο) μεθυλο) -4-μεθυλοφαινυλο)-6-(υδροξυμεθυλο)τετραϋδρο-2η-πυρανο-3,4,5-τριολης με l-προλινη και με κιτρικο οξυ
BRPI0815170A2 (pt) Composição farmacêutica que compreende um inibidor de sglt 2
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
CL2008003940A1 (es) Compuestos derivados de morfolino pirimidina sustituida; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de cancer, enfermedades inflamatorias, enfermedades obstructivas de las vias aereas, enfermedades inmunes o enfermedades cardiovasculares.
NO20080801L (no) Aerosolformulering for inhalering av beta-agonister
UA102534C2 (en) Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]-dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
TW200736235A (en) Dibenzyl amine compounds and derivatives
DE602006006536D1 (de) Trockene Aripiprazolformulierungen
IT1395149B1 (it) Macchina per la lavorazione di pannelli di legno utilizzati per la composizione di mobili per l'arredamento d'interni.
NO20074162L (no) Makrolider med anti-inflammatorisk aktivitet
NO20082613L (no) Karbohydratsammensetning som kan oppnas fra middelhavsfrukt
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
ITBO20060748A1 (it) Confezione per articoli da fumo
NO20081102L (no) Anvendelse av modifiserte trematerialer for fremstilling av gjenstander
NO20090562L (no) Sammensetninger for behandling av kroniske degenerative inflammatoriske tilstander
AR057174A1 (es) Mezclas
MX2009003459A (es) Derivados de 2,3,3-trimetilciclopent-3-encarbaldehido utiles como odorantes.
ATE487488T1 (de) Neuartige antibiotische zusammensetzungen
TW200738652A (en) Dibenzyl amine compounds and derivatives
ATE412862T1 (de) Kühlvorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application